| Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjects. | |
| | |
MedLine Citation:
|
PMID: 3403100 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The pharmacokinetics and relative bioavailability of pentoxifylline, from a new sustained-release formulation (Oxopurin) and from a standard sustained-release formulation (Trental-400), were compared in 8 healthy adult male volunteers. After a single oral dose of 400 mg Oxopurin, a mean maximal plasma concentration (Cmax) of 164 +/- 62 micrograms/l was obtained after 2.2 h (tmax). After an identical dose of Trental-400, a peak plasma concentration of 123 +/- 33 micrograms/l was obtained after 2.4 h. Plasma levels of pentoxifylline were determined by a new HPLC assay which was developed as part of this study and makes possible monitoring plasma levels of pentoxifylline for 14 h after a single dose. The mean relative bioavailability of pentoxifylline from Oxopurin was 1.30 +/- 0.19 relative to that of Trental-400. As the rate and the extent of absorption of pentoxifylline was not significantly different after the administration of the two investigated formulations, it can be concluded that Oxopurin is bioequivalent to Trental-400. |
| | |
Authors:
|
I Raz; J Ben-David; Z Hussein; E Samara |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: International journal of clinical pharmacology, therapy, and toxicology Volume: 26 ISSN: 0174-4879 ISO Abbreviation: Int J Clin Pharmacol Ther Toxicol Publication Date: 1988 Apr |
Date Detail:
|
Created Date: 1988-09-20 Completed Date: 1988-09-20 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8003415 Medline TA: Int J Clin Pharmacol Ther Toxicol Country: GERMANY, WEST |
Other Details:
|
Languages: eng Pagination: 206-8 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine B, Hebrew University-Hadassah Medical Center, Jerusalem, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Biological Availability Chromatography, High Pressure Liquid Delayed-Action Preparations Humans Male Pentoxifylline / administration & dosage, pharmacokinetics* Reference Values Theobromine / analogs & derivatives* |
| Chemical | |
Reg. No./Substance:
|
0/Delayed-Action Preparations; 6493-05-6/Pentoxifylline; 83-67-0/Theobromine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pharmacokinetics of aspirin and chloramphenicol in normal and leprotic patients before and after dap...
Next Document: Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure.